Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings
1. ANGO to report Q1 earnings on October 2. 2. Projected loss of 12 cents per share indicates potential ongoing challenges. 3. Quarterly revenue expected to rise to $72.69 million, showing growth. 4. Analysts maintain Buy ratings, projecting targets from $16 to $17. 5. Shares rose 4% to $11.17 prior to earnings release.